International Brain Health Coalition Launches 30×30×50 Brain Challenge
News related to:International Brain Health Coalition · 2 min read
NEW YORK, Oct. 5, 2026 /CourierPR/ -- The International Brain Health Coalition (IBHC) has launched a global initiative aimed at transforming brain health science into practical, real-world applications. The coalition, coordinated by the Atria Research and Global Health Institute (ARGHI), brings together leaders from medicine, life sciences, technology, finance, and the United Nations to address the growing burden of neurological and cardiometabolic conditions.
The IBHC's first major commitment is the 30×30×50 Brain Challenge. By 2031, the coalition aims to reduce stroke incidence by 30 percent in 30 cities and increase cognitive screening in primary care by 50 percent. This ambitious goal is designed to establish a validated, replicable model that can be adopted by cities, health systems, and countries worldwide.
Dr. David Dodick, Chair of the IBHC and Chief Science and Medical Officer at the Atria Health Institute, emphasized the urgent need for action.
The IBHC's inaugural project is the 30×30×50 Brain Challenge. London, Ontario, Canada, and Oslo, Norway, have been chosen as the launch cities. In London, the CanDo Brain Health Implementation Initiative is underway, a two-year trial involving up to 800 participants. This initiative uses AI-and-human coaching to target blood pressure, activity, sleep, and other proven drivers of cognitive decline, anchored by the Western Institute for Neuroscience at Western University.
Oslo, Norway, is leveraging the AI-Mind research environment at Oslo University Hospital and the University of Oslo. The project combines multimodal AI, cognitive assessment, EEG, blood-based biomarkers, and longitudinal home monitoring to identify individuals at increased risk of cognitive decline before overt dementia develops.
Dr. Regina Benjamin, the 18th United States Surgeon General, highlighted the importance of equitable access to brain health resources.
The coalition's partners include UN Women, Thrive Global, Western University, the Western Institute for Neuroscience, the AI-Mind Institute (Norway), Eli Lilly and Company, Bristol Myers Squibb, the Royal Bank of Canada, the American Heart Association, the Women's Alzheimer's Movement, Microsoft, NeuroCentury, and more. Each partner brings unique expertise to the table, ensuring a comprehensive approach to brain health.
The Atria Research and Global Health Institute, a 501(c)(3) organization, serves as the host and coordinator of the IBHC. Its mission is to transform evidence into equity, closing the gap between what science knows and what communities receive. The institute designs, tests, validates, and scales models for the early detection, early intervention, and prevention of stroke and dementia in primary care and community settings worldwide.
In summary, the International Brain Health Coalition is making significant strides in addressing the global burden of neurological and cardiometabolic conditions. By focusing on practical implementation and collaboration, the coalition aims to improve brain health outcomes for millions of people around the world.